22.76
Schlusskurs vom Vortag:
$22.53
Offen:
$22.98
24-Stunden-Volumen:
518.75K
Relative Volume:
1.06
Marktkapitalisierung:
$1.31B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.89%
1M Leistung:
+8.85%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
Omada Health Inc Stock (OMDA) Company Profile
Firmenname
Omada Health Inc
Sektor
Branche
Telefon
888-987-8337
Adresse
500 SANSOME STREET, SAN FRANCISCO
Vergleichen Sie OMDA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
OMDA
Omada Health Inc
|
22.76 | 1.30B | 0 | 0 | 0 | 0.00 |
![]()
VEEV
Veeva Systems Inc
|
279.08 | 45.01B | 2.97B | 809.93M | 1.33B | 4.87 |
![]()
TEM
Tempus Ai Inc
|
87.07 | 15.02B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
73.60 | 13.61B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
95.59 | 7.95B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
38.58 | 6.72B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omada Health Inc Stock (OMDA) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-09-05 | Eingeleitet | Robert W. Baird | Neutral |
2025-07-01 | Eingeleitet | Barclays | Overweight |
2025-07-01 | Eingeleitet | Canaccord Genuity | Buy |
2025-07-01 | Eingeleitet | Evercore ISI | Outperform |
2025-07-01 | Eingeleitet | Goldman | Buy |
2025-07-01 | Eingeleitet | JP Morgan | Overweight |
2025-07-01 | Eingeleitet | Morgan Stanley | Overweight |
2025-07-01 | Eingeleitet | Needham | Buy |
Alle ansehen
Omada Health Inc Aktie (OMDA) Neueste Nachrichten
Omada Health: Multiple Indicators Convince Me The Growth Outlook Remains Healthy - Seeking Alpha
Omada Health, Inc. (NASDAQ:OMDA) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Omada Health (NASDAQ:OMDA) Stock Price Down 5.9%Here's What Happened - MarketBeat
Omada Health (NASDAQ:OMDA) Upgraded to Hold at Baird R W - MarketBeat
Omada simplifies and accelerates IGA deployment while lowering total cost of ownership - Yahoo Finance
United States 7MM Digital Therapeutics for Diabetes Market - openPR.com
New Omada Health Analysis Shows Long-Term Weight Maintenance Post-GLP-1 Discontinuation, Challenging Industry Assumptions - Yahoo Finance
Omada Health Develops Threat Model to Assess AI Risks in Healthcare - geneonline.com
Omada Health, Inc.(NasdaqGS: OMDA) added to NASDAQ Composite Index - MarketScreener
Baird initiates coverage on Omada Health stock with Neutral rating By Investing.com - Investing.com Australia
Omada Health shares fall 2.23% intraday after Baird initiates coverage with a Neutral rating and $24 price target. - AInvest
Baird Initiates Omada Health at Neutral With $24 Price Target - MarketScreener
Baird initiates coverage on Omada Health stock with Neutral rating - Investing.com
Heartflow, Inc. shares rise 2.21% premarket after new research from Omada Health demonstrates lower healthcare utilization and spending for patients using virtual physical therapy programs. - AInvest
Omada Health announce research on cost savings of virtual physical therapy - TipRanks
Omada Health Study Shows Virtual PT Saves on Medical Care and Costs. - AInvest
Omada Health Study Finds Virtual Physical Therapy Saves Significant Costs for Musculoskeletal Conditions - AInvest
New Research from Omada Health Demonstrates Significant Cost Savings of Virtual Physical Therapy - Yahoo Finance
$1,000+ Per Patient: Omada's Virtual Physical Therapy Outperforms Traditional Care in Major Cost Study - Stock Titan
Omada Health shares fall 1.75% premarket ahead of senior management's participation in Morgan Stanley's Global Healthcare Conference. - AInvest
Heartflow, Inc. shares rise 2.87% premarket after Omada Health's senior management participation in Morgan Stanley's Global Healthcare Conference. - AInvest
Omada Health shares rise 3.31% intraday after announcing participation in Morgan Stanley's Global Healthcare Conference. - AInvest
Omada Health to Participate in Upcoming Investor Conference - Yahoo Finance
Omada Health, Inc. (NASDAQ:OMDA) Receives $24.57 Average PT from Brokerages - MarketBeat
Healthcare Analysts Bullish on CSL, UnitedHealth, and Omada Health - AInvest
Omada Health stock rises on market debut - MSN
U.S. Digital Therapeutics Market Positioned for Accelerated - openPR.com
Digital health Q2 earnings: New guys win, GLP-1 companies lose - Modern Healthcare
Analysts Offer Insights on Healthcare Companies: Omada Health, Inc. (OMDA), Gilead Sciences (GILD) and Cytokinetics (CYTK) - The Globe and Mail
Omada Health, Inc.: Strong Market Position and Growth Potential Justify Buy Rating - TipRanks
Omada grows revenue, membership in public earnings debut - Healthcare Dive
Omada Health 2025 Q2 Earnings Losses Narrow Sharply, 50% Year-Over-Year Reduction in Net Loss - AInvest
Omada Health revenue jumps 49% year-over-year post-IPO - TechTarget
Goldman Sachs raises Omada Health stock price target to $31 on strong Q2 By Investing.com - Investing.com South Africa
Goldman Sachs raises Omada Health stock price target to $31 on strong Q2 - Investing.com Nigeria
Barclays raises Omada Health PT to $24, maintains Overweight rating. - AInvest
Freedom Broker lowers Omada Health stock price target to $20 from $26 - Investing.com India
Freedom Broker lowers Omada Health stock price target to $20 from $26 By Investing.com - Investing.com South Africa
Omada Health price target raised to $28 from $27 at Canaccord - TipRanks
Omada Health price target raised to $24 from $21 at Barclays - TipRanks
Omada Health Reports Strong Q2 2025 Growth - TipRanks
Omada Health reports Q2 EPS (24c), consensus (13c) - TipRanks
Omada Health beats on revenue in first earnings report since IPO - CNBC
Omada Health Reports Second Quarter 2025 Results - The Manila Times
Earnings Flash (OMDA) Omada Health, Inc. Reports Q2 Revenue $61.4M, vs. FactSet Est of $55.3M - MarketScreener
U.S. Digital Therapeutics Market to Witness Remarkable Growth - openPR.com
Omada Health, Inc. (NASDAQ:OMDA) Receives $23.86 Average PT from Analysts - Defense World
Omada Health’s Strategic Partnerships and AI Leverage Drive Growth and Profitability Outlook - TipRanks
Finanzdaten der Omada Health Inc-Aktie (OMDA)
Es liegen keine Finanzdaten für Omada Health Inc (OMDA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):